Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    TopAbstracts in Rheumatoid Arthritis 10/02/2008 - (DGNews)
    Dose Adjustment Not Necessary in Patients With Rheumatoid Arthritis Treated With TRU-015: Presented at ACCP - (DGDispatch)
    Monitoring of Methotrexate Toxicity Needed When Etoricoxib Is Added to Methotrexate in Rheumatoid Arthritis: Presented at ACCP - (DGDispatch)
    TopAbstracts in Rheumatoid Arthritis 09/18/2008 - (DGNews)
    Golimumab Pharmacokinetics Determined in Patients With Rheumatoid Arthritis: Presented at ACCP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Hepatic Effects of Biologic Agents: Current and Future Issues in the Treatment of Rheumatoid Arthritis
      Cardiovascular Disease in Patients With Rheumatoid Arthritis: Results From the QUEST-RA Study
      Pathology and Treatment of Rheumatoid Arthritis: The Role of IL-6 in Inflammation and Rheumatoid Arthritis
      Systemic Pathology of Rheumatoid Arthritis

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Disseminated Cutaneous Herpes Simplex Virus-1 in a Patient with Rheumatoid Arthritis Receiving Infliximab: A Case Report
        Rheumatoid Nodule of the Thyrohyoid Membrane: A Case Report
        Recurrent Pneumothorax in a Patient with Rheumatoid Arthritis on Leflunomide Treatment: Case Report and Overview of the Literature
        Spontaneous Esophageal Perforation in a Patient with Achalasia Cardia and Rheumatoid Arthritis
        Rheumatoid Arthritis in Thalassemia Intermedia: Coincidence or Association?

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Oxidative Marker Found In Rheumatoid Arthritis Synovial Tissue

        A DGReview of :"Identification of the advanced glycation end products N[epsilon]-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis"
        Annals of the Rheumatic Diseases (ARD Online)

        06/12/2002
        By Anne MacLennan


        For the first time, N-ecarboxymethyllysine has been detected in both rheumatoid and osteo arthritic synovial tissue.

        This N-ecarboxymethyllysine (CML), a marker of oxidative stress, may thus play a role in the pathogenesis of rheumatoid arthritis (RA), report S Drinda and colleagues from the Friedrich Schiller University Jena, Jena, Germany.

        CML's possible role in RA pathogenesis is suggested by different patterns of immunostaining in RA and osteoarthritis (OA) and the presence of CML on macrophages and T cells found in this study. This may be due to presentation of new epitopes which can maintain or even trigger an autoimmune response, these authors propose.

        Generation of advanced glycation end products (AGEs), an inevitable process in vivo, can be accelerated under such pathological conditions as oxidative stress.

        Raised AGE levels have been found in the serum and synovial fluid of patients with RA.

        To detect the presence of CML in RA synovial tissue by immunohistology was the objective of this study, in which frozen synovial tissue samples from 10 RA patients and eight controls (four patients without joint disease and four patients with OA) were treated with rabbit-anti-CML-IgG and goat-antirabbit-IgG.

        Immunostaining was visualised by streptavidine-alkaline phosphatase (chromogen fuchsin), and cell differentiation was performed with antibodies against CD68, CD45RO, and CD20.

        CML was found in the synovial lining, sublining and endothelium in all 10 of the RA and all four of the OA synovial specimens.

        In RA some macrophages (CD68+) and T cells (CD45RO+) showed positive immunostaining for CML, whereas B cells were negative.

        Compared with RA, staining in OA synovial sublining was weak.
        Annals of the Rheumatic Diseases 2002;61:488-492. "Identification of the advanced glycation end products N[epsilon]-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send